Minnesota SF 3722: Prescription drug price transparency act provisions amendments

Status: Referred to Health and Human Services (as of 2024-02-15)

State: Minnesota · Session: 2023-2024 · Bill: SF 3722

Subjects: Drugs and Medicine, Government-State, Health and Health Department

Sponsors: Mann

View Minnesota SF 3722 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.